Patents by Inventor Deric M. Park

Deric M. Park has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of phosphatases to treat tumors overexpressing N-CoR
    Publication number: 20090018142
    Abstract: This invention provides a method of treating a patient suffering from a tumor overexpressing N—CoR comprising administering to the patient a phosphatase ligand, alone or in combination with a retinoid receptor ligand, a histone deacetylase ligand, or both, in amounts effective to treat the patient. This invention also provides a method of inhibiting tumor growth in a patient suffering from a tumor overexpressing N—CoR. This invention further provides a method of identifying a compound or a mixture of compounds capable of inducing differentiation of cells of a tumor overexpressing N—CoR. This invention still further provides a method of determining the likelihood of successfully treating a subject suffering from a tumor overexpressing N—CoR. This invention also provides a method of assessing the likelihood that a patient is suffering from a tumor overexpressing N—CoR.
    Type: Application
    Filed: February 6, 2007
    Publication date: January 15, 2009
    Inventors: Zhengping Zhuang, Edward H. Oldfield, Deric M. Park, Irina Lubensky, Jie Li, John S. Kovach
  • Use of phosphatases to treat tumors overexpressing N-CoR
    Publication number: 20080214569
    Abstract: This invention provides a method of treating a patient suffering from a tumor overexpressing N—CoR comprising administering to the patient a phosphatase ligand, alone or in combination with a retinoid receptor ligand, a histone deacetylase ligand, or both, in amounts effective to treat the patient. This invention also provides a method of inhibiting tumor growth in a patient suffering from a tumor overexpressing N—CoR. This invention further provides a method of identifying a compound or a mixture of compounds capable of inducing differentiation of cells of a tumor overexpressing N—CoR. This invention still further provides a method of determining the likelihood of successfully treating a subject suffering from a tumor overexpressing N—CoR. This invention also provides a method of assessing the likelihood that a patient is suffering from a tumor overexpressing N—CoR.
    Type: Application
    Filed: February 8, 2007
    Publication date: September 4, 2008
    Inventors: Zhengping Zhuang, Edward H. Oldfield, Deric M. Park, Irina Lubensky, Jie Li, John S. Kovach